&lt;i&gt;ALDH1L2&lt;/i&gt; orchestrates redox-growth coupling in renal carcinoma: pan-cancer evidence and mechanistic validation of the ROS-Akt/mTOR/S6K axis. This evidence concerns the gene MTOR and renal carcinoma.